Thus, compared with patients treated with radiotherapy and surgical therapy, patients treated with ADT were older and had worse characteristics, such as higher PSA values at diagnosis, higher Gleason scores, and more progressive TNM-stage, indicating an appropriate indication for primary ADT to treat advanced prostate cancer in this cohort. The gene discussed is KLK3; the disease is prostate carcinoma.